Krishna Fil. Ind (KRISNAFILA)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 62.44% is high, aligning interests with minority shareholders.
• Reported ROCE of 100% suggests efficient use of the small existing capital base.
• Market cap of just ₹5 Cr means even modest absolute profits would be meaningful if operations resume.

Concerns

• Latest quarter has zero sales (₹0 Cr) and negligible/net negative profit (₹-0 Cr), so there is no current earnings stream.
• P/E of 0.00 and unavailable book value/debt-equity data make conventional valuation impossible.
• Piotroski F-Score of 3/9 signals weak financial health.
• Zero dividend, zero sales/profit growth, and ROE of only 2.82% give no evidence of shareholder returns.

AI Analysis

Let me start with what I can see. Krishna Filament is a microcap in plastic products with a ₹5 crore market capitalization and a share price of ₹6. In the latest quarter, sales are ₹0 crore and net profit is ₹-0 crore — meaning the business is, at present, producing no revenue and no earnings. That alone removes the possibility of a Graham-style earnings test. The P/E of 0.00 is meaningless, and with no book value or debt/equity disclosed, I cannot calculate a margin of safety. A 2.82% ROE is poor; a 100% ROCE might sound impressive, but without sales, it is likely an artifact of a tiny capital base, not a demonstration of durable pricing power. The Piotroski F-Score of 3 out of 9 reinforces my caution: financial health is weak on the metrics we do have. Promoter holding of 62.44% is encouraging for alignment, but ownership quality cannot replace operating performance. There is no dividend, no sales growth, no profit growth — nothing that a conservative investor can compound. In Buffett's language, 'It is far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' Here, I don't even know if I'm buying a company or a placeholder with a listing. The price of ₹6 is low, but value must be backed by future cash flows. With no current cash flows, this is a speculation on a turnaround, not an investment. I cannot value it, so I would pass. If the business ever resumes meaningful sales, generates consistent profits, and discloses a clean balance sheet, I would revisit it. Until then, capital preservation demands I sit on my hands.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer